Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Research Alert: Breakthrough Helps Expand Genetic Alphabet

4

Sep 2026

Research Alert: Breakthrough Helps Expand Genetic Alphabet

All known life on earth utilizes the same genetic alphabet, consisting of four letters. Now, researchers at University of California San Diego have demonstrated that one of biology's most essential enzymes can accurately read and transcribe an expanded, eight-letter genetic alphabet.

Ovulation drives women to use conspicuous luxury to attract men

4

Sep 2026

Ovulation drives women to use conspicuous luxury to attract men

Hormonal fluctuations associated with fertility are associated with a greater tendency for women to use conspicuous luxury symbols, potentially to be noticed by men, according to a study published September 2, 2026, in the open access journal PLOS One by Aekyoung Kim of Jeonbuk National University of the Republic of Korea, and colleagues.

Prednisone may impair bone health in children with Duchenne muscular dystrophy

4

Sep 2026

Prednisone may impair bone health in children with Duchenne muscular dystrophy

In a new study published in Scientific Reports, an international and multidisciplinary research team including Binghamton University researchers identified a set of blood proteins that may explain why the corticosteroid prednisone, although beneficial in treating Duchenne muscular dystrophy (DMD), can interfere with childhood growth and bone health.

GLP-1 drugs could reshape fashion and body culture

4

Sep 2026

GLP-1 drugs could reshape fashion and body culture

As GLP-1 medications change American bodies and attitudes about weight, a West Virginia University fashion expert says their influence could reach all the way from consumers' closets to designers' drawing boards and retailers' racks.

Gestational diabetes history linked to earlier development of type 2 diabetes

3

Sep 2026

Gestational diabetes history linked to earlier development of type 2 diabetes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows that, in women that develop type 2 diabetes (T2D), those who had gestational diabetes (GD) when pregnant are developing T2D on average almost 13 years earlier than those who did not.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.